New research demonstrated that a low daily dose of mycophenolate mofetil (MMF) in combination with pegloticase may offer meaningful clinical benefits for patients with chronic kidney disease (CKD) and uncontrolled gout.
The findings will be…
Pegloticase Plus Low-Dose MMF Boosts Gout Control While Protecting Kidney Function
